Humoral immune-response to a SARS-CoV-2-BNT162b2 booster in inflammatory arthritis patients who received an inactivated virus vaccine
Ann Rheum Dis
.
2022 Apr 13:annrheumdis-2022-222189.
doi: 10.1136/annrheumdis-2022-222189.
Online ahead of print.
Authors
Josefina Durán
1
,
Paula Isabel Burgos
2
,
Nicole Le Corre
3
,
Cinthya Ruiz Tagle
4
,
Constanza Martinez-Valdebenito
3
,
Mauricio Castro
5
,
Valentina Metcalfe
6
,
Paula Niemann
6
,
M Elvira Balcells
4
Affiliations
1
Department of Rheumatology, Pontificia Universidad Católica de Chile, Santiago, Chile jgduran@uc.cl.
2
Department of Rheumatology, Pontificia Universidad Católica de Chile, Santiago, Chile.
3
Department of Pediatric Immunology and Infectious Diseases, Pontificia Universidad Católica de Chile, Santiago, Chile.
4
Department of Infectious Diseases, Pontificia Universidad Católica de Chile, Santiago, Chile.
5
Department of Statistics, Pontifiicia Universidad Católica de Chile, Santiago, Chile.
6
Pontificia Universidad Católica de Chile, Santiago, Chile.
PMID:
35418480
DOI:
10.1136/annrheumdis-2022-222189
No abstract available
Keywords:
Arthritis; Biological Therapy; COVID-19; Vaccination.